Word

GALOMIC

Status

Pending

Status Code

638

Status Date

Friday, May 10, 2024

Serial Number

98184207

Mark Type

3

Filing Date

Monday, September 18, 2023

Trademark Owner History

E-THERAPEUTICS PLC

Classifications

40 Custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid

9 Downloadable and recorded computer software for use in the field of pharmaceuticals, medicines and drug delivery, namely, for evaluating, analysing, and interpreting information contained in databases to identify new biological targets and gene-disease associations; downloadable and recorded computer software for facilitating the targeted delivery of pharmaceutical and medical preparations; downloadable and recorded computer software for facilitating the targeted delivery of pharmaceutical and medical preparations for silencing or inhibiting gene expression; downloadable and recorded computer software for facilitating the targeted delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs); downloadable and recorded computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug delivery; downloadable and recorded software using artificial intelligence for machine learning for facilitating the delivery of pharmaceutical and medical preparations; downloadable and recorded software using artificial intelligence for machine learning for facilitating the delivery of pharmaceutical and medical preparations targeting genes and silencing or inhibiting gene expression; downloadable and recorded software using artificial intelligence for machine learning for facilitating the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs); downloadable and recorded software using artificial intelligence for machine learning for facilitating the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs), all for targeting genes and silencing or inhibiting gene expression; electronic databases for use in the field of pharmaceuticals, medicines and drug delivery recorded on computer media; electronic databases for use in the field of gene therapy recorded on computer media; electronic databases for use in the field of gene therapy, namely, the delivery of pharmaceutical and medical preparations recorded on computer media; electronic databases for use in the field of gene therapy, namely, the delivery of pharmaceutical and medical preparations targeting and silencing or inhibiting of genes recorded on computer media; electronic databases for use in the field of gene therapy, namely, the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs) recorded on computer media; downloadable and recorded computer platform software for use in the field of pharmaceuticals, medicines and drug delivery, namely, for evaluating, analysing, and interpreting information contained in databases to identify new biological targets and gene-disease associations; downloadable and recorded computer software platforms for use in the field of pharmaceuticals, medicines and drug delivery, namely, for evaluating, analysing, and interpreting information contained in databases to identify new biological targets and gene-disease associations; downloadable and recorded computer software for enabling the searching and retrieval of data relating to pharmaceuticals, medicines and drug discovery; downloadable and recorded software for the analysis of data relating to pharmaceuticals, medicines and drug discovery; downloadable and recorded search engine software for use in the field of pharmaceuticals, medicines and drug discovery; downloadable and recorded search engine software for the searching, retrieval, indexing and analysis of data relating to pharmaceuticals, medicines and drug discovery

5 Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; drug delivery agents that facilitate the delivery of pharmaceutical preparations targeting genes and silencing or inhibiting gene expression; drug delivery agents that facilitate the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs); drug delivery agents that facilitate the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs), all for targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; short interfering RNA-based (siRNA) medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; nucleic acid-based drugs (NABDs) for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation

42 Scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking gene expression, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and, pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; drug discovery services relating to RNAi-based pharmaceuticals and medicines; drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; drug discovery services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; scientific and technical data analysis in relation to pharmaceuticals and medicines; scientific and technical data analysis in relation to RNAi-based medicines; scientific and technical data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific and technical data analysis in relation to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design, development, creation and maintenance of computer platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; design, development, creation and maintenance of computer platforms and computer software enabling the searching and retrieval of data relating to pharmaceuticals, medicines and drug discovery; design, development, creation and maintenance of computer platforms and computer software for the analysis of data relating to pharmaceuticals, medicines and drug discovery; design of and providing temporary use of online non-downloadable search engine software for use in the field of pharmaceuticals, medicines and drug discovery; design of and providing temporary use of online non-downloadable search engine software for the searching, retrieval, indexing and analysis of data relating to pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) services featuring computer software platforms using artificial intelligence and machine learning software and databases for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations all for use in the fields of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) services featuring computer software platforms using artificial intelligence and machine learning software and databases for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating RNAi-based medicines and pharmaceuticals, short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation, all for use in the fields of pharmaceuticals, medicines, and drug discovery; design and development of computer-simulated models for use in the field of pharmaceuticals, medicines and drug discovery; providing temporary use of online non-downloadable computer software for evaluating, analysing, and interpreting information contained in databases to identify new biological targets and gene-disease associations, all for use in the field of pharmaceuticals, medicines and drug delivery; providing temporary use of online non-downloadable computer software for facilitating the targeted delivery of pharmaceutical and medical preparations, all for use in the field of pharmaceuticals, medicines and drug delivery; providing temporary use of online non-downloadable computer software for facilitating the targeted delivery of pharmaceutical and medical preparations for silencing or inhibiting gene expression, all for use in the field of pharmaceuticals, medicines and drug delivery; providing temporary use of online non-downloadable computer software for facilitating the targeted delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs), all for use in the field of pharmaceuticals, medicines and drug delivery; providing temporary use of online non-downloadable computer for machine learning for use in the field of pharmaceuticals, medicines and drug delivery; providing temporary use of online non-downloadable computer software using artificial intelligence for machine learning for facilitating the delivery of pharmaceutical and medical preparations, all for use in the field of pharmaceuticals, medicines and drug delivery; providing temporary use of online non-downloadable computer software using artificial intelligence for machine learning for facilitating the delivery of pharmaceutical and medical preparations targeting genes and silencing or inhibiting gene expression, all for use in the field of pharmaceuticals, medicines and drug delivery; providing temporary use of online non-downloadable computer software using artificial intelligence for machine learning for facilitating the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs), all for use in the field of pharmaceuticals, medicines and drug delivery; providing temporary use of online non-downloadable computer software using artificial intelligence for machine learning for facilitating the delivery of RNAI-based and short interfering RNA-based (siRNA) medicines and pharmaceuticals, and nucleic acid-based drugs (NABDs), all for targeting genes and silencing or inhibiting gene expression, all for use in the field of pharmaceuticals, medicines and drug delivery; Software as a Service (SaaS) services featuring software using artificial intelligence and machine learning software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations databases all in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS) services featuring software using artificial intelligence and machine learning for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating RNAi-based medicines and pharmaceuticals, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation, all for use in the fields of pharmaceuticals, medicines and drug discovery; provision of information, advice and consultancy services relating to all of the aforesaid

The mark consists of a square. The word "GalOmic" appears inside of the square in stylized font. A diagonal line appears between the letters "l" and "O".
Color is not claimed as a feature of the mark.

Trademark Events

Sep 21, 2023

New Application Entered

Oct 4, 2023

New Application Office Supplied Data Entered

Oct 5, 2023

Notice Of Design Search Code E-Mailed

May 10, 2024

Assigned To Examiner